AIM
WST icon

AIA Investment Management’s West Pharmaceutical WST Stock Holding History

AIA Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$97K Buy
352
+96
+38% +$25.4K 0.02% 237
2020
Q2 		$58K Buy
256
+144
+129% +$28.3K 0.01% 221
2020
Q1 		$17K Hold
112
– – ﹤0.01% 336
2019
Q4 		$17K Buy
+112
New +$16.3K 0.02% 302

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIA Investment Management's WST Position: Q3 2020 in Review

AIA Investment Management increased its West Pharmaceutical (WST) stake by 38% in Q3 2020, buying an estimated $25.4K and bringing the position to 352 shares worth $97K. The position accounts for 0.02% of the portfolio, ranked #237.

AIA Investment Management first reported a position in WST in Q4 2019 and has held it in 4 quarters since. 573 funds tracked by Wall St. Rank hold WST as of Q3 2020.

  • AIA Investment Management held 352 shares of West Pharmaceutical worth $97K as of Q3 2020.
  • AIA Investment Management bought 96 West Pharmaceutical shares in Q3 2020, an estimated $25.4K.
  • West Pharmaceutical made up 0.02% of AIA Investment Management's portfolio in Q3 2020, its #237 holding.
  • AIA Investment Management first reported a position in West Pharmaceutical in Q4 2019 and has held it in 4 quarters since.
  • 573 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.